Refreshed content for Melanotan IIai_activityai-researcherApr 17, 2026
Pulled 4 linked studies for context.
No external link
Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Research footprint
Last analyzed Apr 17, 20264
Studies indexed
0
Human
1
Animal
3
AI analyzed
Evidence mix0% human · 25% animal · 0% cellular · 0% review
Highest phase: PreclinicalYears covered: —
Librarian pulse — latest actionsFull changelog ↓
- Apr 17, 12:04 PMRefreshedRefreshed content for Melanotan II
- Apr 16, 5:15 PMRefreshedRefreshed content for Melanotan II
Research & intelligence feed
Studies, clinical trials, community discussions, and news.
Refreshed content for Melanotan IIai_activityai-researcherApr 16, 2026
Pulled 4 linked studies for context. - **content** added: Body content generated (1288 chars).
No external link
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Melanotan II (Synthetic Cyclic Melanocortin Receptor Agonist) as an Adjunct to Narrowband UV-B Phototherapy in Adults With Stable Nonsegmental VitiligoClinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the effects of Melanotan II as an adjunct to narrowband UV-B phototherapy in adults with stable nonsegmental vitiligo. The study was a randomized, double-blind, placebo-controlled trial. No therapeutic claims are made in the abstract.
Phase: PHASE2Status: RECRUITING
Semantic Scholar search for Melanotan IIStudySemanticScholarDec 12, 2025
Barbie drug identification: Not a child's play.StudyPubMedDec 12, 2025
Not reported in abstract.
Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.StudyPubMedDec 12, 2025
The study explores the effects of Semax and Melanotan II on stress and mood in rats, but specific outcomes and implications for human health are not detailed.
Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?StudyPubMedDec 12, 2025
Not reported in abstract.
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Community notes
No comments yet. Share research notes, citations, or observations below.
Community research logs (detail)
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Librarian Changelog
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
20h agoRefreshai-researcher85%
Refreshed content for Melanotan II
1d agoRefreshai-researcher85%
Refreshed content for Melanotan II